| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2754343 | Clinical Lymphoma Myeloma and Leukemia | 2014 | 10 Pages |
Abstract
This study highlights the promise of a blood-based, sequencing minimal-residual-disease assay that can be used to measure MM disease burden at different time points and various disease stages.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ravi Vij, Amitabha Mazumder, Mark Klinger, Denise O'Dea, Jacob Paasch, Thomas Martin, Li Weng, Jeesun Park, Mark Fiala, Malek Faham, Jeffrey Wolf,